1011-601X_2016_29_5

Author: Zhengguang Wang, Liuyi Dong, Yinan Zhen, Yanan Wang, Dongjiang Qi, Aman Xu, Xiangling Meng and Weiping Li Publishing Date: 2016 E-ISSN: 1011-601X Volume 29 Issue 5 ABSTRACT: We and others have shown that Astragalus extract (AE) regulates various cellular processes including inflammation and apoptosis. It remains elusive whether and how AE modulates apoptosis in gastric cancer cells in vitro and […]

Author: Alamgeer, Muhammad Naveed Mushtaq, Sajid Bashir, Ikram Ullah, Sabeha Karim, Muhammad Rashid, Muhammad Nasir Hayat Malik and Haroon-Ur-Rashid Publishing Date: 2016 E-ISSN: 1011-601X Volume: 29 Issue: 5 ABSTRACT: The aim of present study was to evaluate and compare the hypoglycemic activity of different solvents extracts of Thymus serpyllum in rabbits. Diabetes was induced with single intravenous injection of alloxan

Author: Aziz-ur-Rehman, Muhammad Athar Abbasi, Sabahat Zahra Siddiqui, Ayesha Mohyuddin, Sohail Nadeem and Syed Adnan Ali Shah Publishing Date: 2016 E-ISSN: 1011-601X Volume 29 Issue 5 ABSTRACT: New potent organic compounds were synthesized with an aim of good biological activities such as antibacterial and anti-enzymatic. Three series of sulfonamide derivatives were synthesized by treating N-alkyl/aryl substituted amines (2a-f) with 4-chlorobenzensulfonyl chloride

Author: Daniel Załuski and Helena D Smolarz Publishing Date: 2016 E-ISSN: 1011-601X Volume: 29 Issue: 5 ABSTRACT: The chemical composition and pharmacological activity of E. senticosus cultivated in Poland were investigated. Studies included the assay of TPC and TFC, 2D-TLC identification of phenolic acids, HPTLC-detection of antioxidants, and antioxidative, antileukemic, anti-MMPs properties of E. senticosus. The ethanolic extracts from the

Author: Quratulane Gillani, Muhammad Ali and Furhan Iqbal Publishing Date: 2016 E-ISSN: 1011-601X Volume: 29 Issue: 5 ABSTRACT: Interleukin (IL) 6 and 18 plays an important role in inflammatory response following hypoxia ischemia encephalopathy (HIE). Present study was designed to demonstrate the effect of two GABAB receptor antagonists (CGP 35348 and 55845), respectively, on the serum IL6 and IL 18